OrganOx
UKWho owns OrganOx?
OrganOx is a British MedTech company, now owned by Terumo, which acquired it in 2025 from Amadeus Capital Partners, BGF and 2 other investors.
Hand-verified · updated 2026-04-21
Open JSON · CC-BY
Key facts
- ·Fully exited in 2025 to Terumo.
- ·Average hold across 4 realized cycles: 6 years.
- ·4 distinct PE sponsors across ownership cycles.
Ownership history
4 ownership periods · co-invest detected
Amadeus Capital Partners sold OrganOx to Terumo in 2025 after 14 years.
BGF sold OrganOx to Terumo in 2025 after 6 years.
Lauxera Capital Partners sold OrganOx to Terumo in 2025 after 3 years.
La Maison Partners sold Organox to Terumo in 2025 after 2 years.
More from Lauxera Growth I
Other portfolio companies in the same fund.
Sweden
France
Germany
DenmarkMore PE-backed in MedTech
Comparable medtech deals from other GPs.
USQuestions
Who owns OrganOx?
OrganOx is now owned by Terumo, which acquired it in 2025 from Amadeus Capital Partners, BGF and 2 other investors.
When did Terumo acquire OrganOx?
Terumo acquired OrganOx in 2025, buying from Amadeus Capital Partners, BGF and 2 other investors.
Who did OrganOx sell to?
Amadeus Capital Partners, BGF and 2 other investors sold OrganOx to Terumo in 2025 (Trade Sale).
Who has owned OrganOx over time?
OrganOx has been through 4 private-equity ownership periods: Amadeus Capital Partners · via Amadeus IV Digital Prosperity Fund · 2011–2025 · sold to Terumo · (Trade Sale); BGF · via BGF · 2019–2025 · sold to Terumo · (Trade Sale); Lauxera Capital Partners · via Lauxera Growth I · 2022–2025 · sold to Terumo · (Trade Sale); La Maison Partners · via La Maison NextGen · 2023–2025 · sold to Terumo · (Trade Sale).